Research Society on Alcoholism 2012

Network with URBAN ARCH and other NIAAA CHAART consortia at the RSA 35th Annual Scientific Meeting June 23-27, 2012 in San Francisco, California.

Sunday, June 24
2:00-4:00pm Bayview B

Symposium – Alcohol and HIV in Sub-Saharan Africa: Implications for HIV Treatment and Prevention. Organizers/Chairs: Sarah Woolf-King and Judith Hahn

Monday, June 25
8:00-9:00am Grand Ballroom

Plenary Session – RSA Distinguished Researcher Awardee (2012) – Richard Saitz

4:00-6:00pm PACIFIC D-O

Poster Session:

  • Poster # 214 Uganda, Russia, Boston Alcohol Network For Alcohol Research Collaboration on HIV/AIDS (URBAN ARCH) Consortium – Presented by Jeffrey Samet
  • Poster #215 Florida Consortium for HIV/AIDS and Alcohol-Related Research Trials: Focus on Women, Immunology, and Treatment Interventions – Presented by Robert Cook
  • Poster #216 Consortium to Improve Outcomes in HIV/AIDS, Alcohol, Aging & Multi-Substance Use (COMPAAAS ) – Presented by David Fiellin

Wednesday, June 27
7:00pm-midnight Grand Ballroom

RSA Closing Ceremony and Awards Presentations
Distinguished Researcher Award – Richard Saitz

*********************Additional HIV-Alcohol Oral and Poster presentations*******************

SUNDAY, JUNE 24

2:00pm – 4:00pm SYMPOSIUM BAYVIEW A

INTEGRATING ALCOHOL AND DRUG TREATMENT WITH HEALTH SERVICES:
STUDIES IN PRIMARY AND SPECIALTY CARE SETTINGS

3:00 INTEGRATING SUBSTANCE USE AND PSYCHIATRIC DISORDER TREATMENT FOR PATIENTS WITH HIV
Derek Satre, Dept. of Psychiatry, Univ. of California, San Francisco, CA

POSTERS: 4:00PM – 6:00PM PACIFIC D-O

089-S-089 EFFECTS OF ALCOHOL CONSUMPTION ON ANTIGEN-SPECIFIC CELLULAR IMMUNE RESPONSES TO SIV IN RHESUS MACAQUES B. Pahar, et al.

090-S-090 ALCOHOL AND HIV-ANTIRETROVIRAL THERAPY INDUCED LIVER INJURY R. M. Nanau, et al.

146-S-146 WHITE MATTER FIBER COMPROMISE CONTRIBUTES TO ATTENTIONAL AND EMOTIONAL PROCESSING IMPAIRMENT IN ALCOHOLISM, HIV INFECTION, AND THEIR COMORBIDITY T. Schulte, et al.

200-S-200 HIGH RISK ALCOHOL USE IS ASSOCIATED WITH DEPRESSION AND ANXIETY SYMPTOMS IN ACUTE AND EARLY HIV INFECTION E. E. Morgan, et al.

230-S-230 PATIENT COMMITMENT STRENGTH DURING MI, HEALTHCALL PARTICIPATION, AND DRINKING OUTCOMES: RESULTS FROM A RANDOMIZED
TRIAL OF HIV PRIMARY CARE PATIENTS. P. Amrhein et al.

231-S-231 HIV RISK BEHAVIORS AMONG WOMEN IN SUBSTANCE ABUSE TREATMENT: CORRELATES AND PREDICTORS OF CHANGE K.H. Dermen

6:15pm – 8:15pm GRAND C

SYMPOSIUM: INVESTIGATING THE ALCOHOL USE-SEXUAL RISK BEHAVIOR RELATIONSHIP USING SURVEY, EXPERIMENTAL, AND NEUROCOGNITIVE RESEARCH METHODS

MONDAY, JUNE 25

POSTER SESSION 4:00PM – 6:00PM PACIFIC D-O

103-M-425 ETHANOL POTENTIATES HIV-INDUCED APOPTOSIS OF HEPATITIS C VIRUS RNA REPLICATIVE HUMAN HEPATOMA CELLS M.G. Neuman

117-M-439 CHRONIC BINGE ALCOHOL DIFFERENTIALLY MODULATES BRAIN GENE EXPRESSION IN SIV-INFECTED MACAQUES; PRELIMINARY COMPARISON
WITH HIV+ & HIV ENCEPHALITIS. F. Peruzzi, et al.

184-M-506 WHAT IS STRESSFUL FOR HIV-INFECTED WOMEN? CHRONIC GLOBAL STRESS AND TRAUMA-RELATED STRESS AMONG HAZARDOUS/HEAVY
DRINKERS IN HIV PRIMARY CARE. H.E. Hutton, et al.

197-M-519 THE EFFECT OF HEAVY ALCOHOL USE ON HIV VIREMIA DETECTABILITY AND CD4 COUNT AMONG A CLINICAL COHORT OF HIV-INFECTED MEN WHO HAVE SEX WITH MEN (MSM) M.R. Skeer, et al.

199-M-521 ALCOHOL USE AND WOMEN’S SEXUAL BEHAVIORS; RETHINKING HIV RISK FACTORS IN AN EMERGENCY DEPARTMENT AT THE US/MEXICO R Woolard, , et al.

212-M-534 COMORBID ALCOHOL ABUSE AND AFFECTIVE DISORDERS: INDEPENDENT AND CUMULATIVE IMPACT ON VIRAL LOADS AND VIRAL SUPPRESSION IN HIV-POSITIVE OUTPATIENTS J. M. Hormes, , et al.

280-M-602 DRINKING REDUCTION IN HIV PRIMARY CARE: A RANDOMIZED TRIAL OF HEALTHCALL, A TECHNOLOGY-BASED ENHANCEMENT TO BRIEF
MOTIVATIONAL INTERVIEWING D. Hasin, et al.

281-M-603 BRIEF ALCOHOL INTERVENTION AMONG HAZARDOUS AND HEAVY DRINKING HIV INFECTED WOMEN Chander, et al.

282-M-604 CHOOSING A DRINKING GOAL IN MI AMONG HIV PRIMARY CARE PATIENTS: CLINICAL AND DEMOGRAPHIC PREDICTORS. E. Aharonovich, et al.

6:15pm – 8:15pm EVENING SYMPOSIUM BAYVIEW B

INTEGRATIVE RESEARCH ON INJECTABLE EXTENDED-RELEASE NALTREXONE
Organizer/Chair: Sandra Springer

7:40 EXTENDED-RELEASE NALTREXONE FOR HIV+ RELEASED PRISONERS
Sandra Springer

TUESDAY, JUNE 26

POSTER SESSION 4:00PM – 6:00PM PACIFIC D-O

252-T-895 EVIDENCE OF VISUOSPATIAL COMPROMISE OVER 5 YEARS IN ALCOHOLISM-HIV INFECTION COMORBIDITY; RELATION TO DISEASE PROGRESSION. S. A. Sassoon, et al.

280-T-923 DRINKING MOTIVES IN HIV PRIMARY CARE PATIENTS SCREENED INTO BRIEF DRINKING-REDUCTION INTERVENTION. G Fontan, et al.

WEDNESDAY, JUNE 27
POSTER SESSION 1:30PM – 3:30PM

007-W-971 A FAMILY HISTORY OF SUBSTANCE DEPENDENCE OBSCURES THE GROUP DIFFERENCES IN BRAIN FUNCTION ASSOCIATED WITH HIV-1 AND ART. L.O. Bauer

028-W-992 AGE AND ETHANOL CONCENTRATION-DEPENDENT EFFECTS OF ACUTE BINGE DRINKING IN THE HIV-1 TRANSGENIC RAT. S. Sarkar, et al.

086-W-1050 COMBINED EFFECTS OF ALCOHOLISM AND HIV-INFECTION ON SELECTIVE COGNITIVE AND MOTOR FUNCTIONS AND THEIR NEURAL SUBSTRATES R. Fama, et al.

087-W-1051 TOBACCO AND ALCOHOL EFFECTS ON HIV-ASSOCIATED BRAIN DYSFUNCTION R. Cohen, et al.

126-W-1090 ASSOCIATION BETWEEN ILLNESS-SPECIFIC WORRY AND COMORBID ALCOHOL ABUSE IN HIV-POSITIVE OUTPATIENTS J. M. Hormes, et al.

195-W-1159 DISCRIMINATION, ALCOHOL USE, AND HIV RISK BEHAVIORS IN TRANSGENDER ADULTS L., Safford, et al.

205-W-1169 THE EXPERIENCES OF DISCRIMINATION MEASURE IN A RURAL POPULATION: INITIAL VALIDATION AND ASSOCIATION WITH ALCOHOL USE AND HIV-RELATED RISK TAKING K. P. Theall, et al.